EDGAR Filing Documents for 0001144204-17-002826

Form 8-K - Current report:

SEC Accession No. 0001144204-17-002826

Filing Date

2017-01-19

Accepted

2017-01-19 09:28:04

Documents

Period of Report

2017-01-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v457081_8k.htm	8-K	48933
2	EXHIBIT 2.1	v457081_ex2-1.htm	EX-2.1	712768
3	EXHIBIT 10.1	v457081_ex10-1.htm	EX-10.1	86078
4	EXHIBIT 10.2	v457081_ex10-2.htm	EX-10.2	40101
5	EXHIBIT 10.3	v457081_ex10-3.htm	EX-10.3	45250
6	EXHIBIT 10.4	v457081_ex10-4.htm	EX-10.4	16229
7	EXHIBIT 99.1	v457081_ex99-1.htm	EX-99.1	24035
8	GRAPHIC	image_001.jpg	GRAPHIC	2995
9	GRAPHIC	image_002.jpg	GRAPHIC	3211
	Complete submission text file	0001144204-17-002826.txt		983710

Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401

Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600

PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)